Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - 9 months ended Nov. 03, 2018 - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Feb. 03, 2018	$ 140,761	$ 167,501	$ (26,740)
Balance, beginning of period (in shares) at Feb. 03, 2018	15,977,239	15,977,239
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchases	$ 238	$ 238
Employee stock purchases, Shares		28,246
Exercise of stock options, Value	23	$ 23
Exercise of stock options, Shares		177,526
Restricted stock issued, Shares, Gross		108,900
Net share settlement of stock options and restricted stock, Value	(378)	$ (378)
Net share settlement of stock options and restricted stock, Shares		(146,355)
Stock-based compensation expense	1,341	$ 1,341
Repurchase and retirement of common stock, Value	$ (10,358)		(10,358)
Repurchase and retirement of common stock, Shares	(1,082,117)	(1,082,117)
Net loss	$ (10,377)		(10,377)
Balance, end of period at Nov. 03, 2018	$ 121,250	$ 168,725	$ (47,475)
Balance, end of period (in shares) at Nov. 03, 2018	15,063,439	15,063,439